何卓盈醫生 - 普通科
普通科
重點資料
- 醫務委員會註冊已驗證
- 專業資歷香港中文大學內外全科醫學士 · 2021 年醫科畢業
- 保險計劃資料整理中｜查看詳情
關於醫生
何卓盈醫生是香港註冊醫生。
學歷
- 香港中文大學內外全科醫學士2021
保險計劃
醫院轉介
可轉介入以下私家醫院
常見問題
何卓盈醫生好嗎？
何卓盈醫生是香港註冊醫生。資歷及註冊資料來自香港醫務委員會。ok.med 不評分，也不排名。
何卓盈醫生是做什麼的？
何卓盈醫生是普通科醫生。
研究及論文
共 7 篇
- Targeting the innate immune system in treating hepatitis B: prospects for functional cure.Clinical and molecular hepatology · 2026
- The magic of sodium-glucose cotransporter-2 inhibitors: Benefits in metabolic dysfunction-associated steatotic liver disease and type 2 diabetes mellitus: Editorial on "Comparative risk of fibrosis progression with sodium-glucose cotransporter-2 vs. dipeptidyl peptidase-4 inhibitors in metabolic dysfunction-associated steatotic liver disease and type 2 diabetes mellitus with low-to-intermediate fibrosis".Clinical and molecular hepatology · 2026
- Adopting the lancet commission definition of clinical obesity in metabolic dysfunction-associated steatotic liver disease (MASLD).International journal of obesity (2005) · 2026
- The Prevailing Role of Diabetes Mellitus Among Cardiometabolic Risk Factors in Metabolic Dysfunction-associated Steatotic Liver Disease Prognostication.Journal of clinical and experimental hepatology · 2025
- Editorial: Revolutionising Steatotic Liver Disease Diagnosis With Phosphatidylethanol.Alimentary pharmacology & therapeutics · 2025
- Editorial: Decoding the enigma-Navigating complexity in MASLD management.Alimentary pharmacology & therapeutics · 2024
- A case report of rheumatoid neutrophilic dermatitis in a Chinese woman with seropositive rheumatoid arthritis.Modern rheumatology case reports · 2023
論文資料來自 PubMed／Europe PMC，按姓名及機構自動配對；每項均可按連結核對。
僅供參考，不構成醫療建議。 閱讀完整免責聲明